A new intravenous immunoglobulin in adult and childhood idiopathic thrombocytopenic purpura: a review.
This is a review of the work leading to the generalized use of intravenous immunoglobulins (IVIgG) in the treatment of idiopathic thrombocytopenic purpura. Much of the work performed using a reduced and alkylated IVIgG is discussed. Finally, preliminary data on the results being achieved with a new non-modified IVIgG in idiopathic thrombocytopenic purpura (ITP) is dealt with in two studies involving a total of 42 patients.